These clinical observations, coupled with the GWAS finding (1, 10, 11), strongly suggest a role for mARC1 in NASH; however, the mechanistic details remain poorly understood. The gene discussed is MTARC1; the disease is metabolic dysfunction-associated steatohepatitis.